These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9934000)

  • 21. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
    Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
    J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dutch digital breast cancer screening: implications for breast cancer care.
    Timmers JM; den Heeten GJ; Adang EM; Otten JD; Verbeek AL; Broeders MJ
    Eur J Public Health; 2012 Dec; 22(6):925-9. PubMed ID: 22158996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of health care services provided to women enrolled in a community-based breast and cervical cancer screening program.
    Burack R; Latafa J
    J Health Care Poor Underserved; 2009 Aug; 20(3):713-20. PubMed ID: 19648699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Gardner JG; Bapat B; Kramer C
    Eval Program Plann; 2008 May; 31(2):136-44. PubMed ID: 18359084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
    Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the costs of mammographic screening program in the city of Florence].
    Spagnolo G; Zappa M; Paci E; Giorgi D; Rosselli del Turco M
    Epidemiol Prev; 1995 Dec; 19(65):330-7. PubMed ID: 8852082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Lo Sasso AT; Rost K; Beck A
    Med Care; 2006 Apr; 44(4):352-8. PubMed ID: 16565636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breast cancer screening, outside the population-screening program, of women from breast cancer families without proven BRCA1/BRCA2 mutations: a simulation study.
    Jacobi CE; Nagelkerke NJ; van Houwelingen JH; de Bock GH
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):429-36. PubMed ID: 16537697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a community-based intervention to enhance breast cancer screening practices in Brazil.
    Thuler LC; Freitas HG
    J Eval Clin Pract; 2008 Dec; 14(6):1012-7. PubMed ID: 18759754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between method of detection of breast cancer and stage of disease, method of treatment, and survival in women aged 40 to 49 years.
    Maibenco D; Daoud Y; Phillips E; Saxe A
    Am Surg; 1999 Nov; 65(11):1061-6. PubMed ID: 10551757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021.
    Hunter DJ; Drake SM; Shortt SE; Dorland JL; Tran N
    Cancer Detect Prev; 2004; 28(6):453-60. PubMed ID: 15582269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fixed-facility workplace screening mammography.
    Reynolds HE; Larkin GN; Jackson VP; Hawes DR
    AJR Am J Roentgenol; 1997 Feb; 168(2):507-10. PubMed ID: 9016236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
    Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
    Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simulated lifetime costs of three types of employer-based, periodic, breast cancer screening programs for working-age women.
    Griffiths RI; Griffiths CB; Powe NR
    Am J Health Promot; 1994; 9(2):137-46. PubMed ID: 10150714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a surveillance programme for women with a family history of breast cancer.
    Reis MM; Tavakoli M; Dewar J; Goudie D; Cook A; McLeish L; Young D; Kenyon J; Steel M
    J Med Genet; 2009 May; 46(5):319-23. PubMed ID: 19279022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Encouraging screening mammograms. Results of the 1988 Connecticut Breast Cancer Detection Awareness Campaign.
    Gregorio DI; Kegeles S; Parker C; Benn S
    Conn Med; 1990 Jul; 54(7):370-3. PubMed ID: 2394096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A screening mammography program. Staying alive and making it work.
    Monsees BS; Destouet JM
    Radiol Clin North Am; 1992 Jan; 30(1):211-9. PubMed ID: 1732928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical breast examination in a comprehensive breast cancer screening program: contribution and cost.
    Feigin KN; Keating DM; Telford PM; Cohen MA
    Radiology; 2006 Sep; 240(3):650-5. PubMed ID: 16926322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.